VanCleave, A., Palmer, M., Fang, F., Torres, H., Rodezno, T., Li, Q., . . . Tao, J. (2020). Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway. Oncotarget.
Chicago Style CitationVanCleave, Ashley, et al. "Development and Characterization of the Novel Human Osteosarcoma Cell Line COS-33 With Sustained Activation of the MTOR Pathway." Oncotarget 2020.
MLA CitationVanCleave, Ashley, et al. "Development and Characterization of the Novel Human Osteosarcoma Cell Line COS-33 With Sustained Activation of the MTOR Pathway." Oncotarget 2020.
Warning: These citations may not always be 100% accurate.